Figure 1From: KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants Representative microphotographs of immuno-histochemical p53 (A, A’, B, B’) and p16 (C, C’, D, D’) staining are shown. A, A’, C, C’: serous ovarian borderline tumor (s-BOT); B, B’, D, D’: implants associated with s-BOT(s). Scale bars in A/A’ equal 100 μm and apply to A-D/A’-D’.Back to article page